NDC 0069-0502
Xeljanzxr 22 mg tablet, film coated, extended release
On the label: Pfizer Laboratories Div Pfizer Inc.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Pfizer Asia Manufacturing Pte Ltd | Singapore, Singapore | Makes the active ingredient and tests it | Problems found, fixed voluntarilyOct 18, 2023 · 6 inspections |
| Pfizer Ireland Pharmaceuticals Unlimited Company | Ringaskiddy, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyOct 25, 2024 · 6 inspections |
| Viatris Pharmaceuticals LLC | Barceloneta, PR, United States | Makes it and tests it | No problems foundJun 13, 2025 · 8 inspections, 1 with FDA action |
| Pfizer Manufacturing Deutschland GmbH | Freiburg im Breisgau, Germany | Tests it, packages it and labels it | Problems found, fixed voluntarilyJul 2, 2025 · 8 inspections |
| Viatris Pharmaceuticals LLC | Vega Baja, PR, United States | Tests it, packages it and labels it | Problems found, fixed voluntarilyMay 18, 2026 · 11 inspections |
Product details
- Generic drug
- Tofacitinib: every company that makes it
- Form
- tablet, film coated, extended release, oral
- Strength
- 22 mg
- Approval
- NDA NDA208246
- On the market since
- Jan 21, 2020
- Package NDCs
0069-0502-30- Official label
- DailyMed (National Library of Medicine), updated Sep 25, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?